首页> 美国卫生研究院文献>other >Transgenic Mice Carrying the H258N Mutation in the Gene Encoding the β-Subunit of Phosphodiesterase-6 (PDE6B) Provide a Model for Human Congenital Stationary Night Blindness
【2h】

Transgenic Mice Carrying the H258N Mutation in the Gene Encoding the β-Subunit of Phosphodiesterase-6 (PDE6B) Provide a Model for Human Congenital Stationary Night Blindness

机译:携带磷酸二酯酶-6(PDE6B)的β亚基的基因中携带H258N突变的转基因小鼠提供了人类先天性平稳夜盲症的模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in the β-subunit of cGMP-phosphodiesterase (PDE6β) can lead to either progressive retinal disease, such as human retinitis pigmentosa (RP), or stationary disease, such as congenital stationary night blindness (CSNB). Individuals with CSNB in the Rambusch pedigree were found to carry the H258N allele of PDE6B (MIM# 180072); a similar mutation was not found in RP patients. This report describes an individual carrying the H258N allele, who presented with generalized retinal dysfunction affecting the rod system and a locus of dysfunction at the rod-bipolar interface. Also described are preclinical studies in which transgenic mice with the H258N allele were generated to study the pathophysiological mechanisms of CSNB. While Pde6brd1/Pde6brd1 mice have severe photoreceptor degeneration, as in human RP, the H258N transgene rescued these cells. The cGMP-PDE6 activity of dark-adapted H258N mice showed an approximate three-fold increase in the rate of retinal cGMP hydrolysis: from 130.1 nmol × min−1 × nmol−1 rhodopsin in wild-type controls to 319.2 nmol × min−1 × nmol−1 rhodopsin in mutants, consistent with the hypothesis that inhibition of the PDE6β activity by the regulatory PDE6γ subunit is blocked by this mutation. In the albino (B6CBA × FVB) F2 hybrid background, electroretinograms (ERG) from H258N mice were similar to those obtained from affected Rambusch family members, as well as humans with the most common form of CSNB (X-linked), demonstrating a selective loss of the b-wave with relatively normal a-waves. When the H258N allele was introduced into the DBA background, there was no evidence of selective reduction in b-wave amplitudes; rather a- and b-wave amplitudes were both reduced. Thus, factors other than the PDE6B mutation itself could contribute to the variance of an electrophysiological response. Therefore, caution is advisable when interpreting physiological phenotypes associated with the same allele on different genetic backgrounds. Nevertheless, such animals should be of considerable value in further studies of the molecular pathology of CSNB.
机译:cGMP-磷酸二酯酶(PDE6β)β亚基的突变可导致进行性视网膜疾病(例如人视网膜色素变性(RP))或静止性疾病(例如先天性静止性夜盲症(CSNB))。 Rambusch谱系中具有CSNB的个体被发现携带PDE6B的H258N等位基因(MIM#180072);在RP患者中未发现类似的突变。该报告描述了一个携带H258N等位基因的个体,该个体表现出广泛的视网膜功能障碍,影响视杆系统以及视杆-双极界面的功能障碍位点。还描述了临床前研究,其中产生了具有H258N等位基因的转基因小鼠,以研究CSNB的病理生理机制。尽管Pde6b rd1 / Pde6b rd1 小鼠与人RP一样具有严重的感光细胞变性,但H258N转基因拯救了这些细胞。适应黑暗的H258N小鼠的cGMP-PDE6活性显示视网膜cGMP水解速率增加了大约三倍:从130.1 nmol×min -1 ×nmol -1 野生型中的视紫红质对突变体中视紫红质的控制为319.2 nmol×min -1 ×nmol -1 视紫红质,与以下假设相符:调节性PDE6γ抑制PDE6β活性亚基被这种突变所阻断。在白化病(B6CBA×FVB)F2杂种背景中,H258N小鼠的视网膜电图(ERG)与从受影响的Rambusch家族成员以及具有最常见CSNB形式的人(X连锁)获得的视网膜电图相似,证明了选择性相对正常的a波会丢失b波。当将H258N等位基因引入DBA背景时,没有证据表明b波振幅有选择地降低。相反,a和b波的幅度都减小了。因此,除PDE6B突变本身以外的其他因素可能会导致电生理反应的差异。因此,在解释与不同遗传背景下的相同等位基因相关的生理表型时,建议谨慎行事。但是,这种动物在CSNB分子病理学的进一步研究中应具有重要价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号